What are Our Goals at Plus Therapeutics?

(1:25)

Plus Therapeutics CEO Dr. Marc Hedrick - Cancer's Hardest Problems (Clip)

(1:37)

Plus Therapeutics at the NYSE with IPO Edge

(11:33)

Plus Therapeutics (Nasdaq: PSTV) Annual Stockholder Meeting

(15:30)

Plus Therapeutics at the Benzinga Virtual Healthcare Summit

(8:40)

Who is Plus Therapeutics?

(31)

\

(54:7)

Fireside Chat with Plus Therapeutics CEO

(58:10)

Emerging Novel Diagnostic and Therapeutic Approaches for Leptomeningeal Metastases

(1:3:51)

“The Buzz'' Show: Plus Therapeutics (NASDAQ: PSTV) Awarded USD 17.6 Million from State of Texas

(41)

ReSPECT-LM Patient Story | Marlyn, Leptomeningeal Metastases Survivor

(18:38)

What Initially Piqued Plus Therapeutics' Interest in 186RNL?

(48)

How Does Plus Therapeutics Think About Glioblastoma?

(52)

Plus Therapeutics tackles the hardest problems in cancer with targeted radio therapeutics

(8:22)

Plus Therapeutics Significantly Expands Investigational Oncology Drug Pipeline

(1:16)

16 Years of Jacknjellify! 🎂 (Music Video)

(2:39)

Coach Declares the BMS Team is Now Celibate | Blue Mountain State

(4:37)

biogen pharmachem industries Ltd share | biogen pharmachem industries ltd share latest news

(3:12)

Plus Therapeutics Successfully Treats First Patient in Cohort 8 of ReSPECT-GBM Phase 1/2a Trial

(1:4)

Plus Therapeutics' ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases

(2:47)

Plus Therapeutics Announces Plans for Treating Pediatric Brain Cancer

(2:57)